What is the Share Price of SAKAR HEALTHCARE LIMITED?

SAKAR HEALTHCARE LIMITED share price is ₹293.00 As on 09 May, 2025|14:55

Home
>
Stocks
>
SAKAR HEALTHCARE LIMITED

SAKAR HEALTHCARE LIMITED Share Price

Q: What is the Market Cap of SAKAR HEALTHCARE LIMITED?

The Market Cap of SAKAR HEALTHCARE LIMITED is ₹593 As on 09 May, 2025|14:55

Q: What is PE Ratio of SAKAR HEALTHCARE LIMITED?

The P/E ratio of SAKAR HEALTHCARE LIMITED is 39.8 As on 09 May, 2025|14:55

Q: What is PB Ratio of SAKAR HEALTHCARE LIMITED?

The PB ratio of SAKAR HEALTHCARE LIMITED is 5.10 As on 09 May, 2025|14:55

₹ 293.00 +23.95 (8.90%)
Updated on 09-05-2025 2:54 PM

Stock Rating

NSE

Pros 0

Cons 5

SAKAR HEALTHCARE LIMITED Price Performance

Day's Low
₹264.25

Day's High
₹308.15

₹ 293

52-w low
₹210.1

52-w high
₹374.5

293

Day's open
₹265.5
Previous close
₹269.049988
VWAP
₹289.81
Lower price band
₹215.25
Upper price band
₹322.85

Today's Market Action

The last traded share price of SAKAR HEALTHCARE LIMITED was 293.00 up by 8.90% on the NSE. The total volume of shares on NSE and BSE combined was 40,458 shares. Its total combined turnover was Rs 1.17 crores.

SAKAR HEALTHCARE LIMITED Medium and Long Term Market Action

SAKAR HEALTHCARE LIMITED hit a 52-week high of 374.5 on 18-07-2024 and a 52-week low of 210.1 on 28-03-2025. The stock price of SAKAR HEALTHCARE LIMITED is up by 12% over the last one month. It is down by -14.33% over the last one year. Don't forget to check the full stock price history in the table below.

SAKAR HEALTHCARE LIMITED Fundamentals

Market Cap (Cr): 593
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

SAKAR HEALTHCARE LIMITED Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

SAKAR HEALTHCARE LIMITED Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About SAKAR HEALTHCARE LIMITED

Data not available.

SAKAR HEALTHCARE LIMITED FAQ's

What is Share Price of SAKAR HEALTHCARE LIMITED?

What is the Market Cap of SAKAR HEALTHCARE LIMITED?

What is PE Ratio of SAKAR HEALTHCARE LIMITED?

What is PB Ratio of SAKAR HEALTHCARE LIMITED?

What is the CAGR of SAKAR HEALTHCARE LIMITED?

How to Buy SAKAR HEALTHCARE LIMITED Share?

Can I buy SAKAR HEALTHCARE LIMITED from Samco?

How do I buy SAKAR HEALTHCARE LIMITED from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

No Data Available

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 4.75 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.47. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 141 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(09/05/2025)

104

Margin of Safety Index: High

0% People are bullish about SAKAR HEALTHCARE LIMITED

0 % People are bearish about SAKAR HEALTHCARE LIMITED

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %